Mercedesz Balazs

This inventor holds 9 USPTO granted patents and 9 published patent applications and 5 EPO patents. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mercedesz Balazs. Retrieved from https://idiyas.com/inventor/mercedesz-balazs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 9)

% Patents Active = 33.3

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 35(Granted Patents)

Location History:

Hayward, CA (US) (2011 - 2014)
Seattle, WA (US) (2015 - 2017)
Burlingame, CA (US) (2018)

Company Filing History:

Years Active: 2011-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9908931 - Anti-hemagglutinin antibodies and methods of use (2018-03-06),

2. 9745365 - Anti-influenza B virus hemagglutinin antibodies and methods of use (2017-08-29),

3. 9598481 - Anti-hemagglutinin antibodies and methods of use (2017-03-21),

4. 9284365 - Anti-hemagglutinin antibodies and methods of use (2016-03-15),

5. 9067979 - Anti-hemagglutinin antibodies and methods of use (2015-06-30),

6. 8632775 - Apoptotic anti-IgE antibodies (2014-01-21),

7. 8618274 - Nucleic acid encoding apoptotic anti-IgE antibodies (2013-12-31),

8. 8586040 - Methods of using apoptotic anti-IGE antibodies (2013-11-19),

9. 8071097 - Apoptotic anti-IgE antibodies (2011-12-06),

Title: Innovations of Mercedesz Balazs

Introduction

Mercedesz Balazs is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for viral infections. With a total of 9 patents to her name, her work has the potential to impact public health positively.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "Anti-hemagglutinin antibodies and methods of use," which provides anti-hemagglutinin antibodies, compositions comprising these antibodies, and methods for their application. The second patent, "Anti-influenza B virus hemagglutinin antibodies and methods of use," focuses on anti-influenza B virus hemagglutinin antibodies, their compositions, and methods of use. These innovations showcase her dedication to advancing medical science.

Career Highlights

Throughout her career, Mercedesz has worked with leading companies in the biotechnology sector, including Genentech, Inc. and Genetech, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research.

Collaborations

Mercedesz has collaborated with talented individuals in her field, including Min Xu and Ning Chai. These partnerships have fostered an environment of innovation and creativity, further enhancing her contributions to biotechnology.

Conclusion

Mercedesz Balazs is a remarkable inventor whose work in antibody development is paving the way for advancements in medical treatments. Her patents and collaborations reflect her commitment to improving public health through innovative solutions.

Profile summary based on public USPTO records.